Cargando…

SHP2-mediated mitophagy boosted by lovastatin in neuronal cells alleviates parkinsonism in mice

Detalles Bibliográficos
Autores principales:	Liu, Wen, Wang, Meijing, Shen, Lihong, Zhu, Yuyu, Ma, Hongyue, Liu, Bo, Ouyang, Liang, Guo, Wenjie, Xu, Qiang, Sun, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846847/ https://www.ncbi.nlm.nih.gov/pubmed/33514686 http://dx.doi.org/10.1038/s41392-021-00474-x

Ejemplares similares

SHP2 allosteric inhibitor TK-453 alleviates psoriasis-like skin inflammation in mice via inhibition of IL-23/Th17 axis
por: Wang, Meijing, et al.
Publicado: (2022)

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
por: Zhu, Yuyu, et al.
Publicado: (2021)

Lovastatin Alleviates α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy
por: Dai, Lijun, et al.
Publicado: (2021)

T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice
por: Liu, Wen, et al.
Publicado: (2016)

Tyrosine phosphatase SHP2 exacerbates psoriasis‐like skin inflammation in mice via ERK5‐dependent NETosis
por: Ding, Yan, et al.
Publicado: (2022)

SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
por: Zhao, Mingxia, et al.
Publicado: (2019)

Lovastatin Protects against Experimental Plague in Mice
por: Ayyadurai, Saravanan, et al.
Publicado: (2010)

Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis
por: Guo, Wenjie, et al.
Publicado: (2017)

Lovastatin Alleviates Endothelial-to-Mesenchymal Transition in Glomeruli via Suppression of Oxidative Stress and TGF-β1 Signaling
por: Ma, Zejun, et al.
Publicado: (2017)

New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
por: Zhu, Yuyu, et al.
Publicado: (2022)

Structural basis for the biosynthesis of lovastatin
por: Wang, Jialiang, et al.
Publicado: (2021)

Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment
por: Liu, Jia, et al.
Publicado: (2019)

Targeting mitophagy in Parkinson's disease
por: Clark, Emily H., et al.
Publicado: (2020)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
por: Song, Zhendong, et al.
Publicado: (2021)

Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease
por: Diedrich, Madeleine, et al.
Publicado: (2011)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
por: Lin, Ming-Wei, et al.
Publicado: (2019)

Melatonin alleviates renal injury by activating mitophagy in diabetic nephropathy
por: Tang, Hanfen, et al.
Publicado: (2022)

Docosahexaenoic Acid Alleviates Brain Damage by Promoting Mitophagy in Mice with Ischaemic Stroke
por: Sun, Eryi, et al.
Publicado: (2022)

Resveratrol alleviates oxygen/glucose deprivation/reoxygenation-induced neuronal damage through induction of mitophagy
por: Ye, Ming, et al.
Publicado: (2021)

Microbial Production and Biomedical Applications of Lovastatin
por: Seenivasan, A., et al.
Publicado: (2008)

The role of lovastatin in the attenuation of COVID-19
por: Karampoor, Sajad, et al.
Publicado: (2021)

Effects of Lovastatin on Brain Cancer Cells
por: Amadasu, Efosa, et al.
Publicado: (2022)

Differences Between Lovastatin and Simvastatin Hydrolysis in Healthy Male and Female Volunteers: Gut Hydrolysis of Lovastatin is Twice that of Simvastatin
por: Vree, Tom B., et al.
Publicado: (2003)

Therapeutic targeting of mitophagy in Parkinson's disease
por: Masaldan, Shashank, et al.
Publicado: (2022)

Neuronal Mitophagy in Neurodegenerative Diseases
por: Martinez-Vicente, Marta
Publicado: (2017)

Neuronal Mitophagy: Friend or Foe?
por: Doxaki, Christina, et al.
Publicado: (2021)

Urolithin A alleviates neuropathic pain and activates mitophagy
por: Wang, Chenyi, et al.
Publicado: (2023)

Impaired mitochondrial–endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson’s disease
por: Berenguer-Escuder, Clara, et al.
Publicado: (2020)

Lovastatin Differentially Regulates α7 and α4 Neuronal Nicotinic Acetylcholine Receptor Levels in Rat Hippocampal Neurons
por: Borroni, Virginia, et al.
Publicado: (2020)

Improved bioavailability through floating microspheres of lovastatin
por: Kumar, S., et al.
Publicado: (2011)

Lovastatin‐Mediated Changes in Human Tendon Cells
por: Kuzma‐Kuzniarska, Maria, et al.
Publicado: (2015)

Optimization of lovastatin production from Aspergillus fumigatus
por: Mouafi, Foukia E., et al.
Publicado: (2016)

Nanoparticles of Lovastatin: Design, Optimization and in vivo Evaluation
por: Gaber, Dalia A
Publicado: (2020)

Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis
por: Chan, David Y. L., et al.
Publicado: (2007)

Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications
por: Gao, Fei, et al.
Publicado: (2017)

Strengthening the link between mitophagy and Parkinson’s disease
por: Ganley, Ian G
Publicado: (2022)

Deletion of the tyrosine phosphatase Shp2 in Sertoli cells causes infertility in mice
por: Hu, Xiaopeng, et al.
Publicado: (2015)

Loss of SHP-2 activity in CD4(+) T cells promotes melanoma progression and metastasis
por: Zhang, Tao, et al.
Publicado: (2013)

HSP27 Alleviates Cardiac Aging in Mice via a Mechanism Involving Antioxidation and Mitophagy Activation
por: Lin, Shenglan, et al.
Publicado: (2016)

Isolation, Identification, and Characterization of an Unknown Impurity in Lovastatin EP
por: Belwal, Chandrakant, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oehjdof20jts2qj8mm8ljhrctj